Skip to main content
Top
Published in: Abdominal Radiology 3/2021

01-03-2021 | Fatty Liver | Hepatobiliary

Performance of morphologic criteria for the diagnosis of cirrhosis in patients with non-alcoholic steatohepatitis compared to other etiologies of chronic liver disease: effect of level of training and experience

Authors: Roberto Cannella, Navya Dasyam, Su-hun Seo, Alessandro Furlan, Amir A. Borhani

Published in: Abdominal Radiology | Issue 3/2021

Login to get access

Abstract

Purpose

To compare the diagnostic performance of morphologic criteria for detection of cirrhosis in patients with alcoholic liver disease (ALD), hepatitis C (HCV), and non-alcoholic steatohepatitis (NASH).

Methods

One hundred patients (53 male) with different etiologies of chronic liver disease (NASH, n = 41; HCV, n = 39; and ALD, n = 20) and with different degrees of fibrosis on histopathologic examination (74 with cirrhosis) were retrospectively evaluated. Four readers (R1: fellowship-trained abdominal radiologist, R2: community attending radiologist, R3: senior radiology resident/research fellow, R4: junior radiology resident) analyzed the contrast-enhanced CTs for presence of commonly accepted morphologic changes of cirrhosis and portal hypertension. Each reader assigned an overall score (using a 5-point scale) for possibility of cirrhosis based on liver morphology and features of portal hypertension. Diagnostic performance, sensitivity, and specificity for the diagnosis of cirrhosis were calculated and compared between different etiologies of chronic liver disease.

Results

Performance of readers was affected by their level of training. Less experienced readers had overall lower sensitivity for diagnosis of cirrhosis in NASH group (R3: 81.5%, R4: 63.0% compared to 96.3% for both R1 and R2). Sensitivities for detection of NASH cirrhosis significantly decreased for less experienced readers in the absence of ascites (R3: 75.0%, R4: 62.0%) or other features of portal hypertension (R3: 50.0%; R4: 0%). The specificity was consistently high among different etiologies and for all readers (85.7–100%). Inter-reader agreement for morphologic features ranged widely from fair to almost perfect (k: 0.23–0.85).

Conclusion

Cirrhotic changes in NASH are subtler and can be underestimated by less experienced readers.
Literature
1.
go back to reference European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64:1388-1402. European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64:1388-1402.
2.
go back to reference Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328-357.CrossRef Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328-357.CrossRef
3.
go back to reference Eslam M, Sanyal AJ, George J; International Consensus Panel (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 158:1999-2014.e1.CrossRef Eslam M, Sanyal AJ, George J; International Consensus Panel (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 158:1999-2014.e1.CrossRef
4.
go back to reference Brancatelli G, Federle MP, Ambrosini R, Lagalla R, Carriero A, Midiri M, Vilgrain V (2007) Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61:57-69.CrossRef Brancatelli G, Federle MP, Ambrosini R, Lagalla R, Carriero A, Midiri M, Vilgrain V (2007) Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61:57-69.CrossRef
5.
go back to reference Sangster GP, Previgliano CH, Nader M, Chwoschtschinsky E, Heldmann MG (2013) MDCT Imaging Findings of Liver Cirrhosis: Spectrum of Hepatic and Extrahepatic Abdominal Complications. HPB Surg 2013:129396.CrossRef Sangster GP, Previgliano CH, Nader M, Chwoschtschinsky E, Heldmann MG (2013) MDCT Imaging Findings of Liver Cirrhosis: Spectrum of Hepatic and Extrahepatic Abdominal Complications. HPB Surg 2013:129396.CrossRef
6.
go back to reference Lubner MG, Pickhardt PJ (2018) Multidetector Computed Tomography for Retrospective, Noninvasive Staging of Liver Fibrosis. Gastroenterol Clin North Am 47:569-584.CrossRef Lubner MG, Pickhardt PJ (2018) Multidetector Computed Tomography for Retrospective, Noninvasive Staging of Liver Fibrosis. Gastroenterol Clin North Am 47:569-584.CrossRef
7.
go back to reference Harbin WP, Robert NJ, Ferrucci JT Jr (1980) Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 135:273-283.CrossRef Harbin WP, Robert NJ, Ferrucci JT Jr (1980) Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 135:273-283.CrossRef
8.
go back to reference Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T (2002) Cirrhosis: modified caudate-right lobe ratio. Radiology 224:769-774.CrossRef Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T (2002) Cirrhosis: modified caudate-right lobe ratio. Radiology 224:769-774.CrossRef
9.
go back to reference Ito K, Mitchell DG, Gabata T, Hussain SM (1999) Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 211:723-726.CrossRef Ito K, Mitchell DG, Gabata T, Hussain SM (1999) Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 211:723-726.CrossRef
10.
go back to reference Ito K, Mitchell DG, Kim MJ, Awaya H, Koike S, Matsunaga N (2003) Right posterior hepatic notch sign: a simple diagnostic MR finding of cirrhosis. J Magn Reson Imaging 18:561-566.CrossRef Ito K, Mitchell DG, Kim MJ, Awaya H, Koike S, Matsunaga N (2003) Right posterior hepatic notch sign: a simple diagnostic MR finding of cirrhosis. J Magn Reson Imaging 18:561-566.CrossRef
11.
go back to reference Ito K, Mitchell DG, Gabata T (2000) Enlargement of hilar periportal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging 11:136-140.CrossRef Ito K, Mitchell DG, Gabata T (2000) Enlargement of hilar periportal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging 11:136-140.CrossRef
12.
go back to reference Pozo AL, Godfrey EM, Bowles KM (2009) Splenomegaly: investigation, diagnosis and management. Blood Rev 23:105-111.CrossRef Pozo AL, Godfrey EM, Bowles KM (2009) Splenomegaly: investigation, diagnosis and management. Blood Rev 23:105-111.CrossRef
13.
go back to reference Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321.CrossRef Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321.CrossRef
14.
go back to reference Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42:2037-2053.CrossRef Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42:2037-2053.CrossRef
15.
go back to reference Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VW, Kechagias S, Hultcrantz R, Loomba R (2017) Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology 65:1557-1565.CrossRef Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VW, Kechagias S, Hultcrantz R, Loomba R (2017) Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology 65:1557-1565.CrossRef
16.
go back to reference Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases (2009) Liver biopsy. Hepatology 49:1017-1044.CrossRef Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases (2009) Liver biopsy. Hepatology 49:1017-1044.CrossRef
17.
go back to reference Smith AD, Porter KK, Elkassem AA, Sanyal R, Lockhart ME (2019) Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol 213:77-89.CrossRef Smith AD, Porter KK, Elkassem AA, Sanyal R, Lockhart ME (2019) Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol 213:77-89.CrossRef
18.
go back to reference Mamone G, Cortis K, Sarah A, Caruso S, Miraglia R (2018) Hepatic morphology abnormalities: beyond cirrhosis. Abdom Radiol (NY) 43:1612-1626.CrossRef Mamone G, Cortis K, Sarah A, Caruso S, Miraglia R (2018) Hepatic morphology abnormalities: beyond cirrhosis. Abdom Radiol (NY) 43:1612-1626.CrossRef
19.
go back to reference Petitclerc L, Sebastiani G, Gilbert G, Cloutier G, Tang A (2017) Liver fibrosis: Review of current imaging and MRI quantification techniques. J Magn Reson Imaging 45:1276-1295.CrossRef Petitclerc L, Sebastiani G, Gilbert G, Cloutier G, Tang A (2017) Liver fibrosis: Review of current imaging and MRI quantification techniques. J Magn Reson Imaging 45:1276-1295.CrossRef
20.
go back to reference Papadatos D, Fowler KJ, Kielar AZ, Cui J, Sirlin CB (2018) Cirrhosis and LI-RADS. Abdom Radiol (NY) 43:26-40.CrossRef Papadatos D, Fowler KJ, Kielar AZ, Cui J, Sirlin CB (2018) Cirrhosis and LI-RADS. Abdom Radiol (NY) 43:26-40.CrossRef
21.
go back to reference Bolog N, Oancea I, Andreisek G, Mangrau A, Caruntu F (2009) Diagnosis Performance of Different MR Imaging Signs of Cirrhosis: the Caudate to Right Lobe Ratio, the Posterior Right Hepatic Notch, and the Expanded Gallbladder Fossa. Curr Health Sci J 35:16-22.PubMedPubMedCentral Bolog N, Oancea I, Andreisek G, Mangrau A, Caruntu F (2009) Diagnosis Performance of Different MR Imaging Signs of Cirrhosis: the Caudate to Right Lobe Ratio, the Posterior Right Hepatic Notch, and the Expanded Gallbladder Fossa. Curr Health Sci J 35:16-22.PubMedPubMedCentral
22.
go back to reference Venkatesh SK, Yin M, Takahashi N, Glockner JF, Talwalkar JA, Ehman RL (2015) Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography. Abdom Imaging 40:766-775.CrossRef Venkatesh SK, Yin M, Takahashi N, Glockner JF, Talwalkar JA, Ehman RL (2015) Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography. Abdom Imaging 40:766-775.CrossRef
23.
go back to reference Oliva MR, Mortele KJ, Segatto E, Glickman JN, Erturk SM, Ros PR, Silverman SG (2006) Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 30:37-43.CrossRef Oliva MR, Mortele KJ, Segatto E, Glickman JN, Erturk SM, Ros PR, Silverman SG (2006) Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 30:37-43.CrossRef
24.
go back to reference Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J (2020) Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. AJR Am J Roentgenol 214:W20-W26.CrossRef Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J (2020) Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. AJR Am J Roentgenol 214:W20-W26.CrossRef
25.
go back to reference Rustogi R, Horowitz J, Harmath C, Wang Y, Chalian H, Ganger DR, Chen ZE, Bolster BD Jr, Shah S, Miller FH (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35:1356-1364.CrossRef Rustogi R, Horowitz J, Harmath C, Wang Y, Chalian H, Ganger DR, Chen ZE, Bolster BD Jr, Shah S, Miller FH (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35:1356-1364.CrossRef
26.
go back to reference Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, Yin M, Miller FH, Low RN, Hassanein T, Godfrey EM, Asbach P, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL (2016) Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 26:1431-1440.CrossRef Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, Yin M, Miller FH, Low RN, Hassanein T, Godfrey EM, Asbach P, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL (2016) Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 26:1431-1440.CrossRef
27.
go back to reference Reiter R, Tzschätzsch H, Schwahofer F, Haas M, Bayerl C, Muche M, Klatt D, Majumdar S, Uyanik M, Hamm B, Braun J, Sack I, Asbach P (2020) Diagnostic performance of tomoelastography of the liver and spleen for staging hepatic fibrosis. Eur Radiol 30:1719-1729.CrossRef Reiter R, Tzschätzsch H, Schwahofer F, Haas M, Bayerl C, Muche M, Klatt D, Majumdar S, Uyanik M, Hamm B, Braun J, Sack I, Asbach P (2020) Diagnostic performance of tomoelastography of the liver and spleen for staging hepatic fibrosis. Eur Radiol 30:1719-1729.CrossRef
Metadata
Title
Performance of morphologic criteria for the diagnosis of cirrhosis in patients with non-alcoholic steatohepatitis compared to other etiologies of chronic liver disease: effect of level of training and experience
Authors
Roberto Cannella
Navya Dasyam
Su-hun Seo
Alessandro Furlan
Amir A. Borhani
Publication date
01-03-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02719-9

Other articles of this Issue 3/2021

Abdominal Radiology 3/2021 Go to the issue

Classics in Abdominal Radiology

Spalding sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.